This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland

Dennis Berlinger, PhD
Assistant Professor, Center for Translational Immu at UMC Utrecht
Speaker

Profile

Dr. Dennis Beringer is an assistant professor at the Center for Translational Immunology at the University Medical Center Utrecht (UMCU) in the Netherlands. He earned his PhD in structural biology from Utrecht University. Following this, he moved to Monash University in Australia to investigate the molecular details of T cell receptor (TCR) - antigen interactions in autoimmune diseases and cancer. Fascinated by TCR biology, he returned to Utrecht in 2016 to join Prof. Kuball's group at UMCU, where he studied the molecular determinants of tumor-reactive γδTCRs. Currently, his team is focused on optimizing existing γδ-TCR based therapeutics and developing new ones for cancer treatment using protein engineering strategies.

Agenda Sessions

  • Affinity Enhanced γ9δ2TCRs for Immunotherapies Targeting Both Hematological and Solid Tumors

    16:15